首页> 外文期刊>Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA >Total parathyroidectomy with autotransplantation for a rare disease derived from uremic secondary hyperparathyroidism, the uremic leontiasis ossea
【24h】

Total parathyroidectomy with autotransplantation for a rare disease derived from uremic secondary hyperparathyroidism, the uremic leontiasis ossea

机译:自体全甲状旁腺切除术与自体移植术治疗尿毒症继发性甲状旁腺功能亢进症罕见的疾病,即尿毒症白血病

获取原文
获取原文并翻译 | 示例
       

摘要

We described six uremic leontiasis ossea (ULO) patients who underwent total parathyroidectomy with autotransplantation. ULO demonstrated more a systemic disease than a simple craniofacial deformation. The surgery seemed an effective treatment to alleviate secondary hyperparathyroidism and to improve patients' quality of life. ULO may have a high postoperative recurrence tendency. Introduction: ULO is a rare disease derived from uremic secondary hyperparathyroidism (SHPT). Previous studies mostly focused on the craniofacial deformations. This study aims to investigate the systemic features of the disease and the surgical outcomes. Methods: The present study retrospectively assessed six ULO patients who underwent total parathyroidectomy (TPTX) with autotransplantation (AT). Follow-up data were recorded. The follow-up status was considered as "effectiveness" if serum intact parathyroid hormone (iPTH) levels were <150 pg/mL in the first 3 days after surgery, or as "recurrence" if serum iPTH gradually increased >300 pg/mL during follow-up in patients whose status was initially considered as "effectiveness". Results: Craniofacial deformations, short stature, thoracocyllosis, spine malformations, osteodynia, and muscle weakness were observed in all patients. Abnormal pulmonary functions were observed in five patients. After surgery, one patient died from respiratory failure. Surgery was effective in the remaining five patients with relieved osteodynia and stopped craniofacial deformation. A mean follow-up of 7.6 (4 to 12) months was available. Three patients suffered from recurrence of hyperparathyroidism originating from autografts. Conclusions: Our data suggests that ULO is not only a simple disease with craniofacial malformations but is a severe systemic disease leading to increased surgical risks. TPTX with AT seems an effective treatment to relieve SHPT and to improve quality of life. ULO may have a high postoperative recurrence tendency.
机译:我们描述了6例尿毒症性骨质疏松症(OSO)患者,他们接受了自体全甲状腺切除术。与简单的颅面部变形相比,ULO表现出更多的系统性疾病。手术似乎是减轻继发性甲状旁腺功能亢进并改善患者生活质量的有效疗法。 ULO术后复发趋势可能很高。简介:ULO是尿毒症继发性甲状旁腺功能亢进症(SHPT)引起的罕见疾病。先前的研究主要集中在颅面变形上。这项研究旨在调查该疾病的全身特征和手术效果。方法:本研究回顾性评估了6例行全甲状旁腺切除术(TPTX)并自体移植(AT)的ULO患者。记录随访数据。如果手术后前三天的血清完整甲状旁腺激素(iPTH)水平<150 pg / mL,则随访状态为“有效”;如果在手术过程中血清iPTH逐渐升高> 300 pg / mL,则随访状态为“复发”。对最初被认为是“有效”状态的患者进行随访。结果:所有患者均观察到颅面部变形,身材矮小,胸腰椎病,脊柱畸形,骨质疏松和肌肉无力。五例患者观察到肺功能异常。手术后,一名患者死于呼吸衰竭。其余5例骨痛减轻并停止了颅面畸形的手术均有效。平均随访7.6(4至12个月)。三例患者因自体移植而复发甲状旁腺功能亢进。结论:我们的数据表明ULO不仅是一种具有颅面畸形的简单疾病,而且是一种严重的全身性疾病,导致手术风险增加。带AT的TPTX似乎是缓解SHPT和改善生活质量的有效疗法。 ULO可能具有较高的术后复发趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号